Molecular Study of Proteinuria in Patients Treated with B₁₂ Supplements: Do Not Forget Megaloblastic Anemia Type 1

Publisher： Karger

E-ISSN： 1660-2110|118|2|c67-c71

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.118, Iss.2, 2010-12, pp. : c67-c71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Serum CA-15.3 Levels in Patients with Megaloblastic Anemia due to Vitamin B₁₂ Deficiency

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 359-367

Karger

Access to resources Recommend Favorite

Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type‐B inhibitor: A Cross‐Sectional, Cohort Study

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 7, 2015-07 ,pp. : 681-686

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clonogenic Assays Are of Limited Value in Discriminating Patients with Myelodysplastic Syndrome and Patients with Megaloblastic Anemia

Acta Haematologica, Vol. 127, Iss. 2, 2012-01 ,pp. : 118-118

Karger

Access to resources Recommend Favorite

Serum B-Type Natriuretic Peptide in STEMI Patients Treated with PCI

Cardiology, Vol. 103, Iss. 3, 2005-04 ,pp. : 120-

Karger

Access to resources Recommend Favorite

High Percentage of Regulatory T Cells before and after Vitamin B₁₂ Treatment in Patients with Pernicious Anemia

Acta Haematologica, Vol. 133, Iss. 1, 2014-08 ,pp. : 83-88

Karger

Access to resources Recommend Favorite